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This review attempts to follow the trail of the development of epidemiological aspects and
concepts of yellow fever and yellow fever transmission (vectors, vertebrate hosts, spacing of
epidemic outbreaks) with less emphasis on well-documented early history and more emphasis
on epidemiological problems still remaining, plus discussion ofpossible means ofresolving cer-
tain of these problems.
History and epidemiology are intertwined. Epidemics of disease have often been
of importance in influencing the course ofhistory. Among the diseases contributing
in remarkable fashion to the course of human development, yellow fever is out-
standing. The book Yellow Fever edited by G.K. Strode [1] is a source of
epidemiological information relating to the virus, the vertebrate hosts, the vectors,
the worldwide distribution of the disease, the development of the vaccines, up to
mid-century. Knowledge of this disease is lacking in the centuries prior to the great
explorations of the fifteenth and sixteenth centuries and it is not until the seven-
teenth centurythat accounts begin to appear which can be assumed to refer to yellow
fever. Diagnostic confusion undoubtedly existed in the early centuries, and certainly
exists today. Malignant tertian (P. falciparum) malaria was prevalent then. Weil's
disease (leptospirosis: Leptospira icterohemorrhagica) was responsible for
diagnostic confusion, not only in the investigations of Hideyo Nuguchi [2] but also
today. Profligate Nature has no reserve about interjecting cases of yellow fever and
leptospirosis into the epidemic scenario as she does also with malaria, dengue, and
other virus diseases. The viral hepatitis infections are an ever-present source of
worry for the diagnostician. Hepatitis B virus is very prevalent in a number of
African countries, including, for example, Senegal [3], a West African country
where yellow fever has surfaced in several quite widely separated localities over the
past fifteen years [4,5,6,7]. There are diseases only recently discovered: Lassa Fever
[8], Marburg Disease [9], and Ebola Virus Disease [10] which may be confused with
yellow fever.
Diagnostic difficulties pose problems in epidemiological interpretations of
historical data. Nonetheless, it can be considered certain that the yellow fever
epidemics listed in Scott [11], in both Africa and the New World, in large part are
yellow fever, and in certain instances-for example, the 7th Fusiliers in the
Bahamas-are yellow fever with no possibility of admixture with malignant tertian
malaria. The anopheline vector(s) of malaria have a marginal existence on a few of
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the islands and no autochthonous cases of malaria have been reported from the
Bahamas [12].
Carter [131 has written on the history of yellow fever. He studied in detail the
passage of yellow fever through a community, attempting to define the incubation
period of the disease. Josiah Clark Nott, a Connecticut native, settled in Alabama,
had opportunity to study yellow fever at close hand in Alabama. In one epidemic af-
fecting Mobile [14], he lost four of his children, even though he had moved them to
the country, outside of the stricken city. His observations on epidemic spread led
him to postulate an insect vector for yellow fever [15]. His hypotheses are not
precise, formulated as they were fifty years before the first demonstration of a mos-
quito vector of disease. Beauperthuy, a physician working in Angostura (later
Ciudad Bolivar), Venezuela, advanced a similar hypothesis several years later [16].
Nott was a keen observer and set forth clearly his views that yellow fever was what
we would call today a disease with a wide spectrum of clinical manifestations, rang-
ing from mild illness in many cases, sometimes with no or very low fever, to cases
with a fulminating onset, often terminating, in but four or five days, in death.
Carlos Finlay, working in Havana, Cuba, advanced again the hypothesis of a mos-
quito vector of yellow fever [17], and backed up this hypothesis with experimental
work, attempting to show that Aedes aegypti, then known as Stegomyiafasciata,
could be infected by and transmit yellow fever. The U.S. Army group in Havana,
detailed to determine how yellow fever was spread, examined existing theories and
was particularly impressed by Finlay's 1881 mosquito hypothesis. This, coupled
with Carter's observations made in Mississippi in 1898, suggesting an incubation
from first infecting case to later secondary cases of from two to three weeks, in-
fluenced Walter Reed and his associates to explore mosquito vectors. Their deduc-
tions were correct, and they made a convincing demonstration of yellow fever
transmission to human volunteers by the bite of infected Aedes aegypti [18]. The
control of the demonstrated vector brought yellow fever under control in the major
port cities ofthe Old World and the New World. It was thought, in the early decades
ofthe twentieth century, that the disease could be vanquished. However, some unex-
plained outbreaks of yellow fever continued to be seen, particularly in the
hinterlands of South America. Soper and co-workers published a paper [19] which
caused anguish. They described yellow fever in the State ofEspirito Santo, Brazil, in
the absence of Aedes aegypti. Mosquitoes of the genus Haemagogus, a genus quite
closely related to Aedes, were shown to be the vectors for a jungle (or sylvan, or
forest) cycle of yellow fever, in which forest primates served as the vertebrate host,
in places where man was only an occasional invader and, in effect, an accidental
host, not responsible for long-term maintenance of the disease. Bugher et al. [20]
describe the observations of Boshell Manrique that mosquitoes of this genus ap-
peared suddenly at ground level when trees were being felled. This observation led to
numerous later studies on the species composition and vertical distribution of mos-
quito populations (and populations of other biting arthropods) and carried disease
epidemiology into the forest canopy. Mosquitoes of several other genera in the New
Worldwere shown to be possible vectors. In the Old World, Aedes of several species
were shown to maintain a cycle of jungle yellow fever, and mosquitoes of several
other genera were shown to be secondarily involved. Virus was even isolated once
from a Phlebotomus fly.
Thoughts of overall control were banished, but also, it was apparent that the pro-
tection of major population centers remained possible through urban A. aegypti
control programs.
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Another control methodology was introduced in the mid-thirties with the develop-
ment of yellow fever vaccines. French workers developed a mouse brain vaccine
from the French neurotropic strain of virus, given by scarification. Successive
modifications were made, with the vaccine of Peltier and Durieux [21] being used
for immunization of millions in the French West African colonies. The vaccine,
often administered with smallpox vaccine, induced a high degree of immunity, but
there were also vaccine reactions, some of them, particularly in small children, of
encephalitic type. This vaccine has been almost entirely supplanted by the attenuated
17D vaccine, developed by Theiler and Smith [22], and now in use worldwide; it is
produced in embryonated chicken eggs. Reactions to the 17D vaccine are uncom-
mon. Immunity induced is very long-lasting, quite possibly lifelong.
Each of these control options is flawed. The early techniques developed for con-
trol of the vector were refined to the point where Soper et al. [23] in a campaign
backed by the Brazilian government and the Rockefeller Foundation, announced the
eradication of Aedes aegypti from Brazil. The massive operation was successful, in
the era before DDT was known. When the new insecticides, heralded by DDT, did
arrive it appeared that Soper's painstaking strategy for mosquito control could be
extended and simplified, and at least in the New World the possibility of
hemispheric eradication was entertained. Aedes aegypti was eradicated from many
Central and South American countries. Nature again showed her colors, and gloom
succeeded happiness when it was shown, in the late 1950s, that the mosquitoes were
developing a resistance to DDT and also to other insecticides. The mosquito rein-
vaded many areas where it had been eradicated, and, following its reappearance and
multiplication, dengue epidemics (also Aedes aegypti transmitted) are being seen an-
nually in the West Indies and northern South America. The risk of reappearance of
urban yellow fever is obvious. This brings us to the second point, the vaccine, which
can be afforded and which can protect any person or population immunized. An im-
munization program reaching all the population at risk is difficult to conduct. The
risk perceived does not appear commensurate with the effect involved, and in very
few places are continuing effective vaccination programs in operation today. The
problem for the individual, be this individual an international traveler or a con-
cerned individual living in a yellow fever endemic locale, is not a difficult one. But
for the populations in the hinterlands of Africa or the Americas, it remains a large
problem. The vaccine is not very heat stable, and requires a "cold chain" in order to
guarantee conformity of the vaccine being administered with International Regula-
tions. The development of the air jet vaccination apparatus accelerates a mass vac-
cination campaign greatly. In the event of an outbreak in a major city, today's
approach is to start an immunization program immediately, and to do a thorough
mosquito cleanup, treating and if possible destroying all Aedes breeding places. An
immediate campaign of adulticiding, hoping to kill any infected mosquitoes, as well
as reducing the numbers of mosquitoes, is mounted, with insecticide fogs laid down
by aircraft, and by specially adapted ground-based spraying and fogging vehicles
and portable sprayers. This approach is practical and assures prompt epidemic con-
trol. However, if diagnosis of the first case(s) is not made early, an urban epidemic
could well be in the second or third wave of transmission before control gets started,
and there might easily be several hundred individuals infected, with many deaths.
The unfolding of the jungle yellow fever story, and the implication of primates of
both Old World and New World in a cycle of virus transmission high in the canopy
of tropical rain forests seemed like too simplistic a story to satisfy the critical in-
vestigator. Bugher, in the chapter entitled "The Mammalian Host in Yellow Fever"
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in Strode [1], reports on extensive exploratory work in Africa and tropical America,
particularly Colombia and Brazil, carried out through the 1930s. Investigations were
carried out on several orders of mammals and also on birds and poikilothermic
vertebrates. These investigations dealt with susceptibility, with presence of immu-
nity in native animals, and with interaction of such animals with possible or known
vectors, including vector distribution, activities, and behavior, both at ground level
and in forest canopy. There is an excellent summary of findings through 1950, and
these studies have been supplemented by several later studies, including those of
Henderson et al. [24] in East Africa and Gorgas Memorial Laboratory [25] work
with sloths in Panama. Charles Anderson worked on animals in Colombia and
Trinidad. The demonstration by Beaty and Thompson et al. [26] of the association
of La Crosse virus (a member of the California group of Bunyaviridae) with Aedes
triseriatus, a treehole and discarded automobile tire breeding mosquito, the com-
mon chipmunk, and a deadly encephalitis infection in man, in Wisconsin is a
dramatic example of virus persistence in a limited focus. Thompson and Beaty have
also demonstrated [27] venereal transmission, or horizontal transmission, of virus
from a transovarially infected male to an uninfected female.
Attention has been focused on the monkey-mosquito-monkey cycle, and on
other possible cycles, in hopes of gaining a clear understanding of puzzling
epidemiological aspects of yellow fever virus maintenance in natural surroundings.
In several of the known immense virus endemic regions in Africa and South
America, epidemic outbreaks have occurred after long intervals of apparent
freedom from virus activity. Only a very few study spots exist in the regions in ques-
tion. In such centers, it has not been possible to find the virus in interepidemic inter-
vals, even following careful search among the endemic vertebrate species, and the
endemic vectors and possible vectors. In some of the regions, such as Trinidad, it
has been thought [28] that the existing populations of monkeys are not numerous
enough to maintain the virus in silent fashion over a period of several years. Yet
yellow fever outbreaks have occurred on the island in 1914, possibly in the
mid-1930s (never verified), and verified in 1954, 1959, and 1979.
Loring Whitman, in the chapter "The Arthropod Vectors of Yellow Fever" in
Strode's Yellow Fever [1], gives a thorough exposition of knowledge up to 1950. A
chapter subheading is: "Possibility of Virus Passage from Mosquito to Mosquito."
This is a subset of the epidemiological quest, and the attempt to explain long-
continuing existence of the virus in the face of hostile Nature. Ifthe human popula-
tion is not a permanent reservoir of the virus, if there are questions raised about the
ability of monkey populations to serve as permanent reservoirs, and if no known
small animals fill the bill, possibly a permanent reservoir exists in certain mosquito
species. Marchoux and Simond [29] claimed to have transmitted yellow fever to a
human volunteer (those were heroic days ofepidemiology) by bite ofAedes aegypti
reared from an egg of an Aedes which had been permitted to bite on a yellow fever
patient. Unhappily, the data leave doubt as to the validity of the observation. A
number of later studies failed to confirm the hypothesis oftransovarial transmission
of virus.
Rosen et al. [30] succeeded in demonstrating transovarial passage ofthe viruses of
Japanese encephalitis and ofdengue and this work was soon followed by demonstra-
tion of transovarial passage of the yellow fever virus in Aedes aegypti by Beaty,
Tesh, and Aitken [31]. These breakthroughs were made possible through use of
newly developed techniques of immunofluorescence and "tagged" antibody which
permitted rapid examination of hundreds of thousands of individual mosquitoes.
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The phenomenon demonstrated for yellow fever is a low-level phenomenon, suc-
cessful transovarial passage being at about a 1 percent level. Studies are being under-
taken involving several strains ofA. aegypti, other vectors, and other strains ofvirus
in order to know how far one dares to extrapolate from what has been observed.
Concurrent with these laboratory studies there are field observations from Africa
providing new insights and highlighting new avenues for exploration. Cornet et al.
[5] report Institut Pasteur field studies in the vicinity of Kedougou in southeast
Senegal. They have made numerous isolations of yellow fever from mosquitoes of
the Aedes taylori-furcifer complex. Isolations have been made from female and
male mosquitoes. There has been no overt evidence of yellow fever activity in the
region, as evidenced by recognizable cases of illness in man or monkeys. This focus
remained active for two years, after which the virus has disappeared. The mosquito
complex is under intensive study and it appears that it will be possible to identify the
two Aedes species in field-collected material, and to subject each species to detailed
studies ofsusceptibility, life cycle, and behavior, including feeding preferences. Ger-
main et al. [32] at the Institut Pasteur in Bangui, Central African Republic, report
the isolation ofyellow fever virus from a tick, Amblyomma variegatum, taken from
cattle, and has succeeded in transmitting the virus to a susceptible monkey by bite of
offspring of an infected tick. These findings-the demonstration of transovarial
passage of virus, the finding of infected male mosquitoes in the field (implying
transovarial passage and not excluding venereal passage of virus), and the findings
of infected ticks and infected offspring of infected ticks, capable of transmitting
virus by bite-have provided information of fundamental importance. We do not
know how to evaluate these findings in relation to the epidemiology ofyellow fever.
Will they prove to be of major or minor importance?
Seroepidemiological studies on a large scale, to determine the worldwide distribu-
tion of yellow fever, were possible after Theiler's [33] demonstration of the suscep-
tibility of the Swiss white mouse to yellow fever virus. The first surveys, spanning
the world, were carried out with a mouse neutralization test wherein an immune
serum or a serum to be tested was inoculated intraperitoneally into mice, followed
by intraperitoneal inoculation of a serum containing a measured amount of virus.
The findings delimited the range of yellow fever to Africa south of the Sahara and
north of the Tropic of Capricorn, and to the equatorial and subsequatorial regions
of South and Central America. Extremely few "false" reactions were observed in test
sera from regions known to be free ofyellow fever. The neutralization test used was
a very crude one, or, in other terms, a test very specific for yellow fever, and not in-
fluenced by the antibodies to other flaviviruses which might be present. Yellow fever
is a flavivirus, a group ofviruses liberally distributed around the world, and contain-
ing such agents as the dengues, St. Louis encephalitis virus, Japanese encephalitis
virus, and many others. Modernized neutralization tests are of several types, in-
cluding intracerebral inoculation ofthe virus under test, in adult, weanling, orinfant
mice, and various modifications of cell culture tests and the recently developed
ELISA test (enzyme-linked immunosorbent assay). These tests are plagued with the
cross-reactive antibodies common to the flavivirus group. Had the original
worldwide surveys been attempted with these more sensitive tests, the pattern of
yellow fever immunity would have been much obscured. In modern immunological
studies, even when quite specifically narrowed down, as can be done, for example,
with a specifically designed ELISA test, one cannot differentiate between immunity
induced by an infection with a "wild" strain of yellow fever, as encountered in an
endemic region or during an epidemic, and the immunity induced by an inoculation
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of the 17D vaccine. Studies in yellow fever endemic regions to determine the recent
history of yellow fever are much hampered by antibodies present in people already
vaccinated. One is forced to locate and test remotely situated tribal peoples who
have not been vaccinated, or to limit a study to young children, born after the date
of the last vaccination campaign. Clarke [34] showed that by a technique of dif-
ferential absorption of yellow fever antibodies from a potent immune serum, the
yellow fever virus in unadapted form could be distinguished from the 17D vaccine
virus. Indeed she showed a subtle difference between a virus strain from South
America and one from Africa. The test was a laborious one, involving careful mix-
ing of serum and virus, high-speed centrifuging of the mixture, and then search in
the hemagglutination inhibition test for an antibody moiety not removed by the ab-
sorption and centrifugation procedure. She demonstrated such a moiety in 17D im-
mune serum absorbed by a "wild" virus strain, such as the Asibi strain from West
Africa. In an Asibi immune serum absorbed by the 17D virus antigen, all antibody
was removed. Therefore, the 17D virus has an additional antigen component not
present in the parent (Asibi) virus strain. Instead of its being a selected clone from a
polyvalent "wild" virus, it appears that it is a true mutant. Numerous attempts have
been made to reproduce this mutation event, scrupulously following the original
protocols ofTheiler and Smith, and following new protocols aimed at induction and
selection of mutations. The event has never been repeated. The rapidly evolving
modern field of virus particle isolation and breakdown and separation of com-
ponents, coupled with bioengineering, makes it possible to consider the isolation of
the extra component of the 17D virus particle, and to multiply this antigenic frac-
tion, to be used in highly specific immunological tests. Such a test would be a boon
to yellow fever epidemiology.
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